In Line With the LEAP | 28 Portfolio Rotation Strategy, Bureau Veritas Signs an Agreement to Sell It
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces that it has entered exclusive negotiations with Triton Partners regarding the sale of its Oil & Petrochemicals and Coal testing and inspection business. This strategic divestment is in full alignment with the Group’s LEAP | 28 strategy.
The proposed transaction would include the Oil & Petrochemicals and Coal testing and inspection activities. In 2025, this business generated approximately EUR 450 million in revenue operating a global network across multiple countries, with a significant footprint of operational sites and employees.
This business grew at a lower rate than the Group and is margin dilutive. It is included within Bureau Veritas’ “Optimize value and impact” portfolio and reported under the Agri-Food & Commodities division. The transaction supports the strategic objective to increase exposure to higher growth and margin businesses.
A key milestone in LEAP | 28 portfolio rotation
This transaction represents a significant milestone in Bureau Veritas’ portfolio transformation. Following completion and taking into account other recent acquisitions year-to-date, the Group will have executed approximately 20% portfolio rotation since the launch of LEAP | 28.
“This divestment is fully aligned with our LEAP | 28 strategy and our commitment to actively manage our portfolio,” said Hinda Gharbi, Chief Executive Officer of Bureau Veritas. “The Oil & Petrochemicals and Coal business operates in established and mature markets, and is led by a global team. Under the leadership of Triton Partners, we are confident that this business will continue to develop successfully. This transaction will create shareholders value as Bureau Veritas accelerates its planned portfolio pivots towards higher growth and higher margin activities.”
The transaction, based on an enterprise value of EUR 470 million, implies an EV/EBIT multiple of 11.1x on 2025 results post IFRS16. The disposal will have a positive impact on the Group’s organic growth profile, adjusted operating margin and return on capital employed. The deal is anticipated to be broadly neutral to earnings after closing.
Bureau Veritas intends to redeploy the proceeds towards higher-growth and higher-margin businesses, in line with LEAP I 28 portfolio ambitions.
Transaction terms and timetable
This contemplated transaction, currently under negotiation, will be subject to information and consultation procedures with the relevant employee representative bodies, and could be finalized by the end of Q1 2027, subject to the fulfillment of customary conditions precedent.
***
About Bureau Veritas:
Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress. With a vision to be the preferred partner for customers’ excellence and sustainability, the company innovates to help them navigate change.
Created in 1828, Bureau Veritas’ 82,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.
Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40, CAC 40 ESG, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.
- SLB获得巴西近海超深水项目的重大完井合同
- Boston Oncology和King Fahd Medical City(KFMC)合作在沙特阿拉伯推进本地化细胞与基因疗法
- The Go-No-Go (GNG) Machine is Named by DUPR, Pickleballtournaments.com and The UPA-A as the Official
- 兴达东都时代|燕郊现房 LOFT,低总价小户型地铁好盘
- 金鸿源生态农业网助力产业焕新升级!
- 指尖光学触觉,接近觉人体识别!光码未来低成本光电方案无磁干扰更可靠
- 广东省贵州商会(联盟)暨佛山市贵州省商会 2025 年联欢晚会圆满举办
- 北汽极狐销量何以连续破万?解读背后的增长密码
- 前海人寿广州总医院成功完成全国首批VARIPULSE脉冲房颤消融手术
- 沉迷赌博卖妻卖女,演员吴晓亮被骂到微博沦陷
- 中信国际电讯CPC 荣获多个生态圈伙伴奖项 凝聚协同能力、实践创新价值、共享可持续发展成果
- 让华夏儿女健康美丽的“华康美”又获殊荣
- 代高政现身腾讯WeTV五周年High-Five生日派对,亲切互动获赞无数
- 信树科技完成500万天使轮融资,加速布局中韩跨境电商服务生态
- 揭密广东美之家新型材料有限公司完美诠释了对时尚与个性的不懈追求
- 宝石花医疗携手东软医疗成功举办肿瘤学、放射学、核医学、介入医学专委会学术交流会
- AWS与HUMAIN深化合作,依托NVIDIA AI基础设施及AWS AI芯片协议,共同推动全球人工智能创新
- Bitget 开启 MONAD 链上赚币活动并发放高达 800,000 MON 的交易奖励,庆祝全新加密货币 MON 在该通用交易所上市
- 世贸通英联邦护照移民:圣基茨护照再添美国认证
- 科技甘霖润“甜蜜”:九禾“一施就好”助力来宾蔗农抗旱增收
- 同元软控启动“MWORKS 2026 星火计划”,全年开放免费升级与试用
- 上海赋实科技完成600万元天使轮融资,双轮驱动移动互联网服务生态
- 欧陆科技消费品检测网络扩大在华业务,设立常州实验室,加强支持“中国制造”走向全球
- 科创出海2024 Go Sailing 太平山徒步赛圆满落幕
- Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disea
- 裕利医药收购拜耳旗下Zam-Buk®与Vapex®品牌,强化健康消费品布局
- 丘祖堂创始人邱国琴受聘为尼日利亚驻华大使馆健康顾问
- 上海礼智信影视文化传媒出品的《中华五千年.还玉格格》正式开拍
- 2025第二届外交官非遗盛典盛大启幕 文明互鉴共绘非遗新图景
- DearMom斩获天猫金婴奖:以“安全系统”重新定义新生儿婴儿车





